Our data establishes a link from IL-10RA regulation to IDO expression and function, suggesting that IL-10RA polymorphisms may not only influence the IL-10/IL-10 receptor pathway but also control IDO activity in the development of early-onset IBD. The gene discussed is IDO1; the disease is inflammatory bowel disease.